KalVista Pharmaceuticals (KALV) Amortization of Deferred Charges (2015 - 2020)
KalVista Pharmaceuticals recorded quarterly Amortization of Deferred Charges of $145000.0 in Q1 2020, up 7.41% quarter-over-quarter from $135000.0 in Q4 2019.
KalVista Pharmaceuticals' Amortization of Deferred Charges history runs 3 years deep, the most recent figure standing at $145000.0 for Q1 2020.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | KalVista Pharmaceuticals | 1.44 Bn | 1.25 Bn | 56.41 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jan 31, 2020 | 145,000.00 |
| Jan 31, 2020 | 145,000.00 |
| Oct 31, 2019 | 135,000.00 |
| Oct 31, 2019 | 135,000.00 |
| Jul 31, 2019 | 138,000.00 |
| Jul 31, 2019 | 138,000.00 |
| Jun 30, 2015 | 73,000.00 |
| Jun 30, 2015 | 73,000.00 |
| Mar 31, 2015 | 84,000.00 |
| Mar 31, 2015 | 84,000.00 |